Latin American Bioinformatics Market (Genomics, Proteomics & Drug Design) Worth $627 Million by 2017 - New Report by MarketsandMarkets

In Latin America, bioinformatics is now widely recognized as a crucial field for research and development in agricultural, veterinary, and human health sciences. http://www.marketsandmarkets.com/Market-Reports/latin-american-bioinformatics-market-2908323.html

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

Major Player are Agilent Technologies, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC Bio (Denmark)

(PRWEB) March 25, 2014

The “Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017” analyzes and studies the major market drivers, restraints, opportunities, and challenges in Brazil, Mexico, Chile, Argentina, Peru, and Rest of Latin America.

Browse more than 133 market data tables with 23 figures spread through 257 pages and in-depth TOC on "Latin American Bioinformatics Market"
http://www.marketsandmarkets.com/Market-Reports/latin-american-bioinformatics-market-2908323.html

Early buyers will receive 10% customization on this report.

Latin American bioinformatics market was valued at $232 million in 2012 and is poised to grow at a CAGR of 22% from 2012 to 2017, to reach $627 million by 2017.

Inquiry Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=2908323

Based on the use of bioinformatics, the various sectors covered in this report are medicine, agriculture, environment, animal, forensic, academics, and others (homeland security and defense, law-enforcement groups, bioweapon creation, antibiotic resistance, and evolutionary biotechnology).

The segments in the bioinformatics application market are genomics, proteomics, chemoinformatics, molecular phylogenetics, metabolomics, transcriptomics, and others (glycomics, cytomics, physiomics, and interactomics). Genomics contributed the highest share to the bioinformatics market in 2012.

Ask for Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=2908323

The Latin American bioinformatics market displays lucrative growth potential. It is propelled by the rising number of training and development programs on usage of bioinformatics tools, which leads to an increase in the use of bioinformatics tools by industrial and academic bioinformaticians in life sciences research. In addition, the market is further driven by the high concentration of bioinformatics research institutes in Latin America that aim to facilitate the use of bioinformatics in life sciences research. Increasing pharmaceutical innovations as well as increasing R&D spending are factors that unfold new opportunities for the application of bioinformatics in the drug discovery process in Latin America.

However, the dearth of skilled personnel and facilities to ensure the proper use of bioinformatics products and services and the dearth of advanced and innovative bioinformatics tools and algorithms are limiting the growth of the market in Latin America. In addition, hurdles such as the heavy tax burden pose as a key challenge for the entry of new companies into the Latin American bioinformatics market.

The dominant players in the Latin American bioinformatics market are Agilent Technologies, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC Bio (Denmark).

Browse Related Reports:

Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Research & Forensic), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) – Global Forecasts to 2017
http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017
http://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/healthcareit
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets


Contact

Follow us on: Contact's Google Plus